Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

A study by scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) introduces a more cost-effective, scalable ...

Imdelltra is associated with improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell lung cancer.

Nearly a year after winning an accelerated approval for its DLL3-targeting small cell lung cancer (SCLC) therapy Imdelltra, ...

Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to ...

Australia Lung cancer, a significant global health challenge, is primarily classified into non-small cell lung cancer (NSCLC) and small cell lung cancer. Despite advancements in targeted therapies and ...

The firm previously said it will test the CER T-cell therapy CER-1236 in blood cancers after receiving FDA manufacturing clearance.

1:30 ‘The effects will be devastating’: Projected tariffs, layoffs spark calls for worker support Small and medium business leaders say they could have to make minor adjustments to their ...

FACIT gets 'elbows up' on building local health innovation companies that strengthen Ontario's prosperity ...

THOUSANDS AND THOUSANDS AND THOUSANDS OF SMALL BUGS CALLED ZOOPLANKTON GROWING FROM THE BACTERIA IN THE EXCESS RICE STRAW. IT MAKES BUGS. BUT BUGS ARE THE LIQUID GOLD FOR CALIFORNIA’S ECONOMY.

The cellphones were paid for by the California Protocol Foundation, a nonprofit funded by donations that often pays for events and gubernatorial trips, and did not involve taxpayer funds.